# MiNK Therapeutics, Inc.: Form 8-K, filed Aug 10, 2023

- Company: [MiNK Therapeutics, Inc.](/companies/inkt.md) (CIK 1840229)
- Form: 8-K
- Filed: 2023-08-10
- Accepted by EDGAR: Aug 10, 2023, 11:30 ET
- Period: 2023-08-10
- Accession: 0001171843-23-005189
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1840229/000117184323005189/f8k_081023.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1840229/000117184323005189/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1840229/000117184323005189/f8k_081023.htm

Filed Aug 10, 2023.
Source: SEC EDGAR, the filing index for accession 0001171843-23-005189. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.